Gerresheimer at Interpack Düsseldorf: Glass and Plastic Packaging Products for the Pharmaceutical Industry

Date: 10 May 2011
Source: Gerresheimer AG
Today, chronically ill people can administer their medication simply and reliably with drug delivery systems such as asthma inhalers and insulin pens.

Patients, who receive an injection from their doctor, use a nasal spray to relieve cold symptoms or take cough medicine or tablets get in touch with Gerresheimer products. The Gerresheimer Group is exhibiting product highlights from all its business divisions at the Interpack fair.

The Tubular Glass Division is showcasing a range of prefillable syringe systems, including its flagship RTF® sterile syringes. Additionally Tubular glass is the basis for a comprehensive range of high quality pharma-ceutical vials, ampoules and cartridges in numerous filling sizes and design variants.

Gerresheimer Moulded Glass supplies a comprehensive range of glass packaging products to the pharmaceuticals, perfume and cosmetics segments, plus special segments of the food and beverage industry. It extends from cough medicine bottles to sophisticated perfume flacons made of colored glass.

The Medical Plastic Systems Division produces custom-made medical systems made of plastic for pharmaceutical, diagnostic and medical applications such as inhalers and insulin pens.

Among other products Plastic Packaging is presenting on Interpack this business division mainly focuses on multilayer vials for sensitive paren-teral medications. This division is particularly famous for its comprehen-sive range of high quality primary packaging products for liquid and solid medications.

Gerresheimer is exhibiting at Interpack, Düsseldorf in Hall 07a, Stand B03. The press conference will be held on May 12, 2011 at 12:00 noon in Room 7A, CCD.South.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group realizes revenues of around one billion Euros and has 10,000 employees at 45 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.

Contact Jens Kürten Director Corporate Communication & Marketing Telephone: +49 211 6181-250 Telefax: +49 211 6181-241 E-Mail:

600450 Gerresheimer at Interpack Düsseldorf: Glass and Plastic Packaging Products for the Pharmaceutical Industry
Date: 10 May 2011
Source: Gerresheimer AG

See more news about:

Others also read

Proprietary laminate windows collect, store energy; convert it to electricityRIVIERA BEACH, FL – An innovative new patented technology transforms office building windows into "solar farms" and allows these structures to reuse collected energy and become self-sufficient in the event of a power outage.
DALLAS, Texas, December 22, 2011 /PRNewswire/ --ReportsnReports adds new market research report 'Solar Photovoltaic (PV) Power - Global Market Size, Installation Prices, Module Market Shares, Market Segmentation, Regulations and Key Country Analysis to 2020' to its store.
The University of Minnesota's historic Folwell Hall completed three years of extensive renovation, just time for the 2011 academic year.
Michael Gai has been named Vice President of Operations at Glass Doctor, following the recent promotion of Mark Liston to President.
We sincerely thank all our members, friends and visitors for being part of GlassOnWeb and its success during 2011.
COLUMBUS, Ohio – Dec. 19, 2011 – Safelite AutoGlass®, the nation’s largest provider of vehicle glass repair and replacement services with a fleet of 6,000, announced it will transition to Ford®.

Add new comment